As concerns about climate change, biodiversity loss, water and plastics pollution continue to grow, sustainability has become a strategic priority for pharmaceutical companies.

We understand pharmaceutical industry challenges
With every challenge comes opportunity. We understand the need to continue providing the best treatments to patients while prioritizing environmental sustainability and resiliency in the supply chain. The industry has an opportunity to address key challenges across the value chain while maintaining operational excellence.
The levers for sustainable transformation are many, and now is the time to act.

Circular economy
The pharma industry relies heavily on various resources and materials, such as chemicals, water and packaging materials that contribute to pollution. Companies need to adopt circular economy practices both in their manufacturing processes and throughout their product life cycles to reduce resource consumption, emissions and waste.

Biodiversity loss
Pharmaceutical companies depend significantly on natural resources for new drug development and production. Companies must better understand their impacts and dependencies on ecosystems to manage risks related to biodiversity loss and ecosystem degradation.

Supply chain management
The vulnerabilities of global pharmaceutical supply chains highlight the need for companies to build supply chain resilience and improve environmental performance across supplier networks.

Climate change
As one of the biggest contributors to greenhouse gas emissions in the healthcare sector, pharma companies face increasing pressure to reduce both direct and indirect emissions across their value chains.

Engaging stakeholders
The use phase of medicine is critical for healthcare. Companies must engage with downstream stakeholders to ensure the optimal impact of upstream actions to reduce their environmental impact.

Ecodesign
Product development is long, costly and highly regulated. At the same time, pharma companies rely on innovation to provide the best medicines to patients. Utilizing ecodesign practices, the industry can reduce the environmental impact of products and packaging.

Digital enablement
As the pharma and healthcare industry embraces sustainable practices along the value chain, requirements for reliable data and transparency are rapidly increasing. Key players need to develop and integrate technology solutions that will help measure, track and report sustainability performance at scale. Managing data flows is becoming pivotal to ensure seamless integration, ethical practices and consistency.

Our Approach in Action
For over a decade, leading pharmaceutical companies have partnered with Quantis to connect sustainability ambition to real business outcomes.
We work together to set priorities, deploy effective and meaningful strategies, and measure and monitor progress.
Ready to align sustainability with business performance?
Quantis pharmaceuticals experts can help you to:
-
Develop integrated, science-informed strategies and roadmaps beyond climate
Focusing solely on carbon can overlook material risks and opportunities across water, biodiversity, land use and plastics. We work with you to assess these interconnected issues, define clear priorities and build structured roadmaps that align environmental considerations with product strategy, sourcing decisions and growth plans.
-
Accelerate and institutionalize sustainable innovation
By collaborating with clients to integrate ecodesign and circular design principles into products and packaging, we help respond to growing consumer demand for transparency while reducing environmental impact across the value chain.
-
Activate your supply chain
We support your teams in driving measurable change across suppliers and value chains, clarifying expectations, aligning incentives and focusing effort where it will have the greatest impact. By strengthening collaboration and accountability across upstream partners, we help translate strategy into practical results
Ready to align sustainability with business performance?
Quantis experts
Latest case studies
Building the foundation for sustainable pharma with the Pharma LCA Consortium and BSI
The LCA consortium, aiming at supporting the technical use of the standard by LCA members, has developed also a Guidance Document with the support of Quantis.
Angelini Industries
Discover how a century-old, family-owned company is embedding sustainability, safety and resilience at the heart of its purpose — partnering with BCG and Quantis to…
Pharma Company
Quantis supported a global pharmaceuticals company in understanding its impacts and dependencies on nature, assessing the related risks and opportunities, and evaluating…
Latest insights
Beyond carbon: Embedding nature risks across the pharma value chain
Why pharma must tackle its hidden dependence on nature to safeguard patients, secure supply chains and build long-term resilience.
What nature-related risks does the pharma industry face?
Clement Turnier explores the connection between pharmaceuticals and nature, outlining key environmental risks.
Navigating sustainability challenges in the pharmaceutical industry in 2025
From environmental transparency to biodiversity preservation, Quantis experts share four key strategies to align the pharmaceutical sector with planetary boundaries.
